Mixed Mode Chromatography Resin Market Size & Growth Forecast 2027–2036, By Segments (Technique, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Mixed Mode Chromatography Resin Market size was worth USD 132.8 million in 2026 and is poised to grow at a 11.69% CAGR between 2027 and 2036, crossing USD 401.18 million by 2036. The industry revenue for 2027 is assessed at USD 145.87 million.
Get more details on this report
Request Free Sample ReportMixed Mode Chromatography Resin Market Intelligence Snapshot
Regional Market Dynamics
- North America captured a 37.42% market share in 2026, driven by its established biopharmaceutical manufacturing base and widespread use of mixed mode resins for efficient biologics purification.
- Asia Pacific is projected to expand at a 13.66% CAGR as bioprocessing capacity grows and manufacturers increasingly adopt advanced purification technologies to improve efficiency, throughput, and separation performance.
Segment Momentum
- Ion Exchange - Hydrophobic held a 53.34% share in 2026 because it combines ionic and hydrophobic interactions in one purification step, improving selectivity while reducing process complexity and supporting efficient impurity removal.
- Biotechnology is growing fastest as biologics development increasingly requires adaptable purification technologies capable of handling complex molecules and evolving process requirements more effectively than traditional approaches.
Market Expansion Drivers
- Rising monoclonal antibody and vaccine production increasing demand for advanced purification technologies.
- Expanding adoption of single-use bioprocessing systems improving purification efficiency and scalability.
- Growth of biopharmaceutical CMOs strengthening demand for cost-efficient chromatography purification solutions.
Leading Market Participants
- Top companies in the mixed mode chromatography resin market include Cytiva (United States), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Bio-Rad Laboratories, Inc. (United States), Tosoh Corporation (Japan), Purolite Corporation (United States), JSR Corporation (Japan), Sepragen Corporation (United States), Repligen Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 132.8 million
- 2027 Estimated Market Size: USD 145.87 million.
- Projected Market Size: USD 401.18 million by 2036
- Growth Forecast: 11.69% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Ion Exchange - Hydrophobic (Technique) | Pharmaceutical (End-use)
- Emerging Opportunity Segment: Hydroxyapatite (Technique) | Biotechnology (End-use)
Market Growth Drivers and Industry Trends
Rising monoclonal antibody and vaccine production increasing demand for advanced purification technologies
Rising production of monoclonal antibodies and vaccines will drive the mixed mode chromatography resin market growth by increasing the need for effective downstream purification technologies capable of handling complex biopharmaceutical mixtures. Mixed mode resins combine multiple interaction mechanisms, allowing them to address purification challenges that may not be efficiently resolved through conventional single-mode chromatography approaches. As biopharmaceutical manufacturers expand production of complex biological products, downstream processes must achieve high purity while maintaining product recovery and process consistency. The ability of mixed mode chromatography to provide selective separation and support the removal of difficult impurities makes these resins valuable in purification workflows for advanced biologic therapies and vaccine products.
Expanding adoption of single-use bioprocessing systems improving purification efficiency and scalability
Increasing adoption of single-use technologies is strengthening the mixed mode chromatography resin market as biopharmaceutical manufacturers seek flexible purification processes that can be scaled while reducing cleaning and cross-contamination requirements. Single-use bioprocessing systems allow facilities to streamline equipment changeovers and adapt production configurations for different biological products, supporting more agile manufacturing operations. Mixed mode chromatography resins can be incorporated into these downstream workflows to improve separation performance for challenging biomolecules and impurities. The combination of disposable processing infrastructure with efficient purification technologies is particularly relevant for manufacturers managing variable production requirements and seeking to optimize facility utilization.
Growth of biopharmaceutical CMOs strengthening demand for cost-efficient chromatography purification solutions
The expansion of contract manufacturing organizations serving the biopharmaceutical industry will propel the mixed mode chromatography resin market by increasing demand for purification technologies that deliver consistent performance across diverse client products and production processes. CMOs must manage different molecular characteristics, process conditions, and manufacturing requirements while maintaining quality and operational efficiency. Mixed mode resins offer additional separation selectivity that can help address complex purification requirements and reduce reliance on multiple processing steps in suitable applications. Their use can support CMOs in developing adaptable downstream workflows while balancing purification performance, resin utilization, process robustness, and overall manufacturing costs.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising monoclonal antibody and vaccine production increasing demand for advanced purification technologies | 2.10% | High | North America, Europe | High | Near Term |
| Expanding adoption of single-use bioprocessing systems improving purification efficiency and scalability | 1.80% | Moderate | North America, Asia Pacific | High | Mid Term |
| Growth of biopharmaceutical CMOs strengthening demand for cost-efficient chromatography purification solutions | 1.50% | Moderate | Asia Pacific, Europe | Medium | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share of 37.42% in 2026 in the mixed mode chromatography resin market, reflecting the region's advanced biopharmaceutical manufacturing capabilities, strong life sciences ecosystem, and substantial demand for sophisticated purification technologies. The growing production of biologics and other complex therapeutic products is increasing the need for efficient separation and purification processes, where mixed mode chromatography can provide enhanced selectivity and process flexibility. Strong research infrastructure, established pharmaceutical manufacturing facilities, and continued investment in bioprocess development further support adoption, particularly as manufacturers seek to improve purification efficiency and process robustness.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by the expansion of biopharmaceutical manufacturing, increasing healthcare investment, and the development of local pharmaceutical and biotechnology capabilities. Growing demand for biologic therapies is encouraging manufacturers to strengthen downstream processing infrastructure and adopt advanced purification technologies. The establishment of new production facilities, expansion of research capabilities, and increasing focus on domestic biomanufacturing are creating additional opportunities for chromatography resin suppliers. As the regional life sciences sector becomes more sophisticated, demand for selective and scalable purification solutions is expected to strengthen further.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Process Efficiency OptimizationGermany emphasizes mixed mode chromatography resins that enhance purification efficiency across pharmaceutical manufacturing and biotechnology research. German organizations continue investing in high-performance separation technologies that improve process consistency and manufacturing productivity.
France 🇫🇷
Biopharma Purification DevelopmentFrance continues integrating mixed mode chromatography resins into pharmaceutical production and life science research activities. French organizations focus on purification platforms that support efficient processing, high product quality, and adaptable workflows for evolving biologic therapies.
Italy 🇮🇹
Research-Driven PurificationItaly is expanding the application of mixed mode chromatography resins across biotechnology research and pharmaceutical manufacturing. Italian laboratories and producers prioritize versatile purification media that improve separation performance while supporting efficient development and production of complex therapeutic products.
Japan 🇯🇵
High-Purity Separation TechnologiesJapan focuses on mixed mode chromatography resins supporting advanced purification workflows for biologics and specialty pharmaceutical production. Japanese laboratories and manufacturers prioritize reliable resin performance, reproducible separation, and compatibility with sophisticated downstream processing requirements.
South Korea 🇰🇷
Biomanufacturing Capability ExpansionSouth Korea is increasing adoption of mixed mode chromatography resins to strengthen biopharmaceutical manufacturing and contract development capabilities. South Korean producers emphasize purification technologies that improve scalability, product quality, and operational flexibility across biologics production.
United States 🇺🇸
Bioprocess Purification FocusThe U.S. mixed mode chromatography resin market is driven by expanding biopharmaceutical purification requirements and process optimization initiatives. U.S. manufacturers and research organizations prioritize resins that improve selectivity, streamline downstream processing, and accommodate increasingly complex biologic molecules.
Segment Leadership and Growth Trends
Mixed Mode Chromatography Resin Market Share (%), by Technique, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportTechnique Segment Analysis: Ion Exchange - Hydrophobic (Largest Segment) vs Hydroxyapatite (Fastest-Growing Segment)
Ion exchange - hydrophobic held the largest share of the mixed mode chromatography resin market at 53.34% in 2026, supported by its ability to combine complementary separation mechanisms for more selective and efficient purification. This technique is particularly valuable when conventional single-mode chromatography does not provide sufficient resolution, enabling manufacturers to address complex biomolecule purification requirements. Its broad utility across biopharmaceutical processing and its compatibility with demanding purification workflows continue to reinforce its leading position.
Hydroxyapatite is the fastest-growing technique segment, driven by its distinctive affinity-based separation characteristics and suitability for complex biomolecules. Its ability to interact with proteins through multiple mechanisms makes it useful for achieving selective purification and removing difficult impurities. Growing demand for highly purified biologics, coupled with increasing interest in advanced chromatography approaches that can improve process efficiency and product quality, is supporting broader adoption of hydroxyapatite-based techniques.
End-use Segment Analysis: Pharmaceutical (Largest Segment) vs Biotechnology (Fastest-Growing Segment)
The pharmaceutical segment accounted for the largest share of the mixed mode chromatography resin market in 2026, reflecting the extensive use of chromatography technologies in drug development and biopharmaceutical manufacturing. Pharmaceutical production requires reliable purification processes to achieve stringent quality, safety, and consistency requirements, creating sustained demand for advanced resin technologies. The growing complexity of therapeutic molecules and increasing emphasis on efficient downstream processing continue to support the segment's strong market position.
Biotechnology is the fastest-growing end-use segment, benefiting from expanding research and development activities involving complex biological molecules and advanced therapeutic modalities. Biotechnology applications increasingly require highly selective purification techniques capable of handling diverse biomolecular characteristics while maintaining product integrity. Greater adoption of biologics and continued innovation in bioprocessing workflows are creating additional opportunities for mixed mode chromatography resins within this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Technique | Ion Exchange - Hydrophobic, Hydroxyapatite, Others | Ion Exchange - Hydrophobic | Hydroxyapatite |
| End-use | Pharmaceutical, Biotechnology | Pharmaceutical | Biotechnology |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the mixed mode chromatography resin market:
1. Cytiva (United States)
2. Merck KGaA (Germany)
3. Thermo Fisher Scientific Inc. (United States)
4. Danaher Corporation (United States)
5. Bio-Rad Laboratories Inc. (United States)
6. Tosoh Corporation (Japan)
7. Purolite Corporation (United States)
8. JSR Corporation (Japan)
9. Sepragen Corporation (United States)
10. Repligen Corporation (United States)
The mixed mode chromatography resin market is progressing through innovations in resin selectivity, purification efficiency, and process scalability tailored for biopharmaceutical applications. Research-driven product enhancements are supporting improved protein separation and downstream processing performance.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Cytiva (United States) | |||||||
| Merck KGaA (Germany) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Danaher Corporation (United States) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Tosoh Corporation (Japan) | |||||||
| Purolite Corporation (United States) | |||||||
| JSR Corporation (Japan) | |||||||
| Sepragen Corporation (United States) | |||||||
| Repligen Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| DuPont | Apr-26 | DuPont launched "AmberChrom™ XT SL" chromatography resins, designed to simplify workflows for oligonucleotide and peptide therapeutics. By providing a pre-slurried format, these resins eliminate the traditional hydration step, enabling biopharmaceutical manufacturers to reduce processing time and improve operational efficiency in complex purification workflows. |
| Repligen Corporation | Dec-25 | Repligen launched a new high-performance resin portfolio, including AVIPure HiPer AAV9, AAV8, and HiPer QA, based on Tantti DuloCore technology. Engineered specifically for viral vector and gene therapy applications, these resins offer higher binding capacities and faster flow rates to meet the evolving productivity requirements of advanced biologic manufacturing. |
| Purolite | May-25 | Purolite introduced "Praesto CH1," a 70µm agarose-based mixed-mode chromatography resin. Designed for challenging downstream processing, it offers high flow rates and enhanced selectivity for complex protein purification, supporting the growing industry demand for robust and cost-effective solutions in monoclonal antibody and recombinant protein production. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Mixed Mode Chromatography Resin Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Purification Stage | Capture, Intermediate Purification, Polishing |
| Biomolecule Type | Monoclonal Antibodies, Recombinant Proteins, Vaccines & Viral Vectors, Nucleic Acids, Other Biomolecules |
| Format | Prepacked Columns, Bulk Resin, Membrane & Monolith Formats |
Mixed Mode Chromatography Resin Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Bioprocess Pipeline Demand by Molecule Type |
|
| CDMO and Biopharma Procurement Landscape |
|
| Downstream Processing Technology Migration Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the mixed mode chromatography resin market?
What is the forecasted size of the mixed mode chromatography resin industry?
How is biologics expansion impacting demand in the mixed mode chromatography resin market?
Why are CMOs increasing adoption of mixed mode chromatography resins?
Why is Ion Exchange - Hydrophobic the leading technique in the mixed mode chromatography resin market?
Why is biotechnology the fastest-growing end-use segment in the mixed mode chromatography resin market?
Why does North America lead the mixed mode chromatography resin market?
What is driving mixed mode chromatography resin market growth in Asia Pacific?
Who are the leading players in the mixed mode chromatography resin landscape?
Our Clients
"The report helped us understand emerging consumer trends in our product category. It clarified where to focus innovation for the next product launch."
LyondellBasell
"The regional forecast section was incredibly useful. We were able to identify two new potential partners in Europe thanks to the vendor mapping you included."
SABIC
"We appreciated how actionable the recommendations were. It guided us to improve supply chain resilience."
Olin Corporation
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Chemicals & Materials Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| American Chemistry Council (ACC) | www.americanchemistry.com |
| European Chemical Industry Council (Cefic) | cefic.org |
| International Council of Chemical Associations (ICCA) | icca-chem.org |
| European Chemicals Agency (ECHA) | echa.europa.eu |
| U.S. Environmental Protection Agency (EPA) | www.epa.gov |
| ASTM International | www.astm.org |
| International Organization for Standardization (ISO) | www.iso.org |
| National Institute of Standards and Technology (NIST) | www.nist.gov |
| Plastics Industry Association (PLASTICS) | www.plasticsindustry.org |
| European Biplastics | www.european-bioplastics.org |
| The Adhesive and Sealant Council (ASC) | www.ascouncil.org |
| National Association of Corrosion Engineers (AMPP) | www.ampp.org |
| Society of Plastics Engineers (SPE) | www.4spe.org |
| International Fertilizer Association (IFA) | www.fertilizer.org |
| CropLife International | croplife.org |
| Packaging Europe | packagingeurope.com |
| Flexible Packaging Association (FPA) | www.flexpack.org |
| Battery Council International (BCI) | batterycouncil.org |
| International Copper Association (ICA) | internationalcopper.org |
| World Steel Association | worldsteel.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization